Cardiovascular Disease in Women Module III: Risk Assessment Tool

Slides:



Advertisements
Similar presentations
NCEP ATP IV GuidelineS: 2013 Update
Advertisements

Cardiovascular Disease In Women: Risk Factors
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.
1 Prediabetes Screening and Monitoring. 2 Prediabetes Epidemiologic evidence suggests that the complications of T2DM begin early in the progression from.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Women & Heart Disease: How are We Different & How Can You Take Care of Yourself.
CONTROLLING YOUR RISK FACTORS Taking the Steps to a Healthy Heart.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
CVD risk estimation and prevention: An overview of SIGN 97.
PAD A Call to Action. PAD: A Call to Action - What is peripheral arterial disease (PAD)? and why is it so dangerous? - Diagnosing PAD in the primary care.
Lipids 101 Cardiology Board Review Med-Peds Style!
Final Exam Tuesday, 6/5, 2 PM Closed book – Essay and MC/TF Determining Energy Needs – p – Indirect calorimetry – Be able to do the calculations.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Chapter 4 Cardiovascular disease
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Understanding blood lipids and glucose How a Healthy Lifestyle can improve your numbers Susan Fullmer, PhD RD Associate Teaching Professor Nutrition, Dietetics,
Cardiovascular Disease in Women Module III: Risk Assessment Tool.
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
Metabolic Syndrome, Diabetes, and Cardiovascular Disease: Implications for Preventive Cardiology Nathan D. Wong, PhD, FACC, FAHA Professor and Director.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.
Cardiovascular Disease in Women Module VII: Evidence-Based Guidelines.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
Global impact of ischemic heart disease World Heart Federation, 2011.
LDL-C target levels (mg/dL)  2 RF:
Department of Family & Community Medicine
Obesity M.A.Kubtan MD - FRCS M.A.Kubtan1. 2  Pulmonary Disease  Fatty Liver Disease  Orthopedic Disorders  Gallbladder Disease  Psychological Impact.
Madhav Vissa. ATP III  Adult Treatment Panel  Guidelines for tx of High Cholesterol  Based on epidemiological evidence about risk factors for CHD.
Evidence-Based Guidelines for Cardiovascular Disease Prevention in Women.
RISK FACTOR FOR CORONARY ARTERY DISEASE
METABOLIC Syndrome: a Global Perspective
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.
Reducing Risk of Heart Disease & Stroke - A Life Long Quest Jeffrey P. Gold, M.D. University of Toledo Medical Center.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
 2010 Cengage-Wadsworth Preventing Cardiovascular Disease Chapter 11.
Slide Source: Lipids Online Slide Library C-Reactive Protein, Metabolic Syndrome, and Risk for CV Events: Women’s Health Study 14,719.
Chapter 14 Patterns in Health and Disease: Epidemiology and Physiology EXERCISE PHYSIOLOGY Theory and Application to Fitness and Performance, 6th edition.
Gender Sensitive Cardiovascular Health Global Implications.
Presented by Slyter Nutrition Consulting Services.
INTERVENTION IS PREVENTION: For A Healthier Community Bronx County Medical Society 10 th Annual National Doctors Recognition Day March 20, 2013 Julie J.
Abstract The metabolic syndrome (MetS) has surpassed smoking as the number one cause of cardiovascular deaths in the US. However, it remains under diagnosed.
Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD
Cardiovascular Disease: Risk Factors and Risk Assessment
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH CRITERIA FOR THE CLINICAL DIAGNOSIS OF THE METABOLIC SYNDROME AS PROPOSED BY THE NCEP-ATP III Metabolic.
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
برنامه غربالگری و بیماریابی بیماری های قلبی عروقی و عوامل خطر آن در استان فارس معاونت بهداشتی دانشگاه علوم پزشکی شیراز واحد غیر واگیر برنامه قلب و عروق.
Heart Disease and Stroke Statistics — 2004 Update
NCEP/Framingham risk scores: Estimate of 10-yr CHD risk in men without CHD VBWG Age (y) 20–34 35–39 40–44 45–49 50–54 55–59 60–64 65–69 70–74 75–79.
Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN 
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Nat. Rev. Gastroenterol. Hepatol. doi: /nrgastro
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Level of risk factor control in the overall sample and by gender
Introduction to: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults BLUF: -Shift from.
Goals & Guidelines A summary of international guidelines for CHD
Cardiovascular Disease in Women Module IX: Presentation Resources and Internet Resources This slide set was updated April 2008.
Preventative Cardiology
Presentation transcript:

Cardiovascular Disease in Women Module III: Risk Assessment Tool This slide set was updated April 2008.

Risk Stratification: High Risk Diabetes mellitus Documented atherosclerotic disease Established coronary heart disease Peripheral arterial disease Cerebrovascular disease Abdominal aortic aneurysm Includes many patients with chronic kidney disease, especially ESRD 10-year Framingham global risk > 20%, or high risk based on another population-adapted global risk assessment tool SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115: 1481-501. Source: Mosca 2007

Risk Stratification: At Risk: > 1 major risk factors for CVD, including: Cigarette smoking Hypertension Dyslipidemia Family history of premature CVD (CVD at < 55 years in a male relative, or < 65 years in a female relative) Obesity, especially central obesity Physical inactivity Poor diet Metabolic syndrome Evidence of subclinical coronary artery disease (eg coronary calcification), or poor exercise capacity on tredtmill test or abnormal heart rate recovery after stopping exercise SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115: 1481-501. Source: Mosca 2007

Definition of Metabolic Syndrome in Women Abdominal obesity - waist circumference > 35 in. High triglycerides ≥ 150mg/dL Low HDL cholesterol < 50mg/dL Elevated BP ≥ 130/85mm Hg Fasting glucose ≥ 100mg/dL SLIDE INFORMATION SOURCE: Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, accessed at www.circulationaha.org on October 25, 2005. The metabolic syndrome is characterized by a constellation of risk factors in one individual. This syndrome increases the risk for CHD at any given LDL-cholesterol level (1). The definition of metabolic syndrome remains controversial. This is the AHA/NHLBI definition. Patients are diagnosed with metabolic syndrome when three of five criteria are met. Patients receiving drug treatment for elevated triglycerides, reduced HDL, hypertension, or high glucose meet the threshhold for each criteria. A cutoff of 31 inches waist circumference for Asian American women should be used(1) (1) Grundy SM, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, accessed at www.circulationaha.org on October 25, 2005. Source: AHA/NHLBI 2005

Risk Stratification: Optimal risk: No risk factors Healthy lifestyle Framingham global risk < 10% SLIDE INFORMATION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115: 1481-501. Source: Mosca 2007

Risk Stratification Calculate 10 year risk for all patients with two or more risk factors that do not already meet criteria for CHD equivalent Use electronic calculator for most precise estimate: www.nhlbi.nih.gov/guidelines/cholesterol/index.htm SLIDE INFORMSTION SOURCE: Mosca L, et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109:672-693. Source: Mosca 2004

SLIDE INFORMATION SOURCE: http://www. nhlbi. nih SLIDE INFORMATION SOURCE: http://www.nhlbi.nih.gov/about/framingham/riskabs.htm, accessed on March 8, 2005. 10 year risk can also be calculated using a pen and paper method. The scoring is demonstrated on this slide and the subsequent one (1). (1) http://www.nhlbi.nih.gov/about/framingham/riskabs.htm, accessed on March 8, 2005. Source: http://www.nhlbi.nih.gov/about/framingham/riskabs.htm

SLIDE INFORMATION SOURCE: http://www. nhlbi. nih SLIDE INFORMATION SOURCE: http://www.nhlbi.nih.gov/about/framingham/riskabs.htm, accessed on March 8, 2005. 10 year risk can also be calculated using a pen and paper method. The scoring is demonstrated on this slide and the previous one (1). (1) http://www.nhlbi.nih.gov/about/framingham/riskabs.htm, accessed on March 8, 2005. Source: http://www.nhlbi.nih.gov/about/framingham/riskabs.htm

Downloadable Scoring Sheet for 10-year CHD event risk The scoring sheet is available at: www.nhlbi.nih.gov/about/framingham/riskabs.htm SLIDE INFORMATION SOURCE: www.nhlbi.nih.gov/about/framingham/riskabs.htm, accessed April 2, 2008. Source: www.nhlbi.nih.gov/about/framingham/riskabs.htm